As shown in Figure 1, nine S100s members, including S100A2/A4/A6/A10/A11/A13/A14/A16/P were significantly upregulated in pancreatic cancer (fold change = 2, p < 0.001). Here, S100A2 is linked to pancreatic neoplasm.